-
-
-
-
-
-
-
QIAGEN Reports Full Results for Q1 2026
-
-
-
-
-
-
-
Parse Biosciences Launches Evercode Whole Transcriptome V4 With Shorter Workflow, Higher Sensitivity and Higher Cell Recovery
-
-
-
-
-
-
-
QIAGEN Unveils QIAsymphony Connect and Showcases New Precision Oncology Innovations at AMP 2025
-
-
-
-
-
-
-
QIAGEN Marks 4,000th QIAcube Connect Placement, Reaffirming Leadership in Automated Sample Processing
-
-
-
-
-
-
-
QIAGEN and GENCURIX Announce QIAcuity Digital PCR IVD Assay Development Partnership
-
-
-
-
-
-
-
QIAGEN delivers solid Q1 2025 results exceeding outlook; will seek shareholder approval to initiate a dividend and new $500 mn repurchase
-
-
-
-
-
-
-
QIAGEN Launches QIAprep& Plasmodium Kit to Strengthen Malaria Research and Surveillance Efforts
-
1,198,614 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

